- List
- By Topic
- On Map
- Search Details

Recruiting, Not yet recruiting, Available Studies | "Stomach Neoplasms"
Need help? See RSS Feeds
Choose a feed type:

Recruiting, Not yet recruiting, Available Studies | "Stomach Neoplasms" (465 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT03023436 | Recruiting | Cytoreductive Surgery Combined With HIPEC and Chemotherapy for Gastric Cancer With Peritoneal Metastasis |
|
|
Interventional | Phase 3 |
|
Other |
|
|
220 | All | 19 Years to 74 Years (Adult, Senior) | NCT03023436 | CLASS - 05 | January 2016 | June 2022 | June 2022 | January 18, 2017 | February 7, 2017 |
|
||
2 | NCT02725125 | Recruiting | Study Evaluating the Efficacy and Safety With CAR-T for Stomach Cancer |
|
|
Interventional | Not Applicable |
|
Industry |
|
|
19 | All | up to 75 Years (Child, Adult, Senior) | NCT02725125 | ACCO-2015-06-04 | EECSC | November 2015 | November 2019 | November 2019 | March 31, 2016 | March 23, 2017 |
|
|
3 | NCT02662959 | Recruiting | Irinotecan as 3rd Line Therapy in Gastric Cancer |
|
|
Interventional | Phase 2 |
|
Other |
|
|
93 | All | 18 Years to 70 Years (Adult, Senior) | NCT02662959 | Med Onc-G 01 | April 2015 | May 2018 | January 26, 2016 | January 26, 2016 |
|
|||
4 | NCT02969122 | Recruiting | Treatment Strategy for Stage IV Gastric Cancer With Positive Peritoneal Cytology as the Only Non-curable Factor |
|
|
Interventional | Not Applicable |
|
Other |
|
|
59 | All | Child, Adult, Senior | NCT02969122 | 2016YJZ35 | Cy-plus | November 2016 | December 2023 | December 2023 | November 21, 2016 | November 28, 2016 |
|
|
5 | NCT02663427 | Not yet recruiting | Serological Screening of Gastric Cancer in Wuxi Region |
|
|
Interventional | Not Applicable |
|
Other |
|
|
5000 | All | 40 Years to 70 Years (Adult, Senior) | NCT02663427 | Z201501 | January 2016 | January 2018 | June 2018 | January 26, 2016 | January 26, 2016 | |||
6 | NCT02594943 | Not yet recruiting | Endodrill vs. Conventional Biopsy. Evaluation of Diagnostic Capacity in Diffuse Gastric Cancer |
|
|
Interventional | Not Applicable |
|
Other |
|
|
20 | All | 18 Years to 85 Years (Adult, Senior) | NCT02594943 | Endodrill II | August 2018 | December 2019 | December 2019 | November 3, 2015 | April 11, 2018 | |||
7 | NCT02679495 | Recruiting | Lifestyle Intervention for Prevention of Gastric Neoplasm |
|
|
Interventional | Not Applicable |
|
Other |
|
|
200 | All | Child, Adult, Senior | NCT02679495 | 2015WS0366 | March 2015 | December 2018 | December 2020 | February 10, 2016 | October 13, 2016 |
|
||
8 | NCT03447106 | Not yet recruiting | Comparison of Open Laparoscopic and Robotic Surgery in Gastric Cancer Resection. |
|
|
Interventional | Not Applicable |
|
Other |
|
|
500 | All | Child, Adult, Senior | NCT03447106 | XJTU1AF-CRF-2018-001 | Cooladvrsigcr | February 28, 2018 | February 28, 2020 | December 31, 2020 | February 27, 2018 | March 2, 2018 |
|
|
9 | NCT02887612 | Recruiting | ctDNA for Prediction of Relapse in Gastric Cancer |
|
|
Observational |
|
Other |
|
|
200 | All | 18 Years to 80 Years (Adult, Senior) | NCT02887612 | ctDNA001 | September 2016 | December 2018 | December 2019 | September 2, 2016 | January 17, 2018 |
|
|||
10 | NCT03170180 | Recruiting | Exploratory Study of Drug Sensitivity Prediction Software (IRCR-DReSS) With Patient-derived Tumor Cells of Metastatic Gastric Cancer |
|
|
Interventional | Phase 2 |
|
Other |
|
|
21 | All | 20 Years and older (Adult, Senior) | NCT03170180 | 2016-12-058 | March 1, 2017 | October 31, 2019 | October 31, 2020 | May 30, 2017 | May 30, 2017 |
|
||
11 | NCT03425773 | Not yet recruiting | Safety and Tolerability Evaluation Study of BVAC-B in Patients With HER2/Neu(Human Epithelial Growth Factor Receptor 2) Positive Gastric Cancer After Failure to Standard Care |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
9 | All | 19 Years and older (Adult, Senior) | NCT03425773 | BVAC-B-P1 | BVAC-B | February 13, 2018 | May 17, 2019 | June 14, 2019 | February 8, 2018 | February 8, 2018 | ||
12 | NCT03027427 | Recruiting | Prospective Evaluation and Molecular Profiling in People With Gastric Tumors |
|
Observational |
|
NIH |
|
|
250 | All | 18 Years to 100 Years (Adult, Senior) | NCT03027427 | 170044 17-C-0044 |
January 12, 2017 | August 31, 2026 | December 31, 2026 | January 23, 2017 | January 2, 2018 |
|
||||
13 | NCT02949258 | Not yet recruiting | Neoadjuvant Chemotherapy With SEEOX Regimen for Borrmann Type 4 Gastric Cancer |
|
|
Interventional | Phase 2 |
|
Other |
|
|
40 | All | 30 Years to 75 Years (Adult, Senior) | NCT02949258 | B4-2016-LGL | NCT-B4 | January 2017 | January 2019 | January 2021 | October 31, 2016 | October 31, 2016 |
|
|
14 | NCT02338518 | Recruiting | Comparison of SEEOX and SOX Regimens in Stage ⅢB/ⅢC Gastric Cancer Patients |
|
|
Interventional | Phase 3 |
|
Other |
|
|
320 | All | 30 Years to 70 Years (Adult, Senior) | NCT02338518 | 20140621 08Z28 |
SVOSA | January 2015 | October 2018 | December 2018 | January 14, 2015 | October 31, 2016 |
|
|
15 | NCT02430636 | Recruiting | Irreversible Electroporation(IRE) For Unresectable Stomach Neoplasms |
|
|
Interventional | Phase 1 Phase 2 |
|
Other |
|
|
30 | All | Child, Adult, Senior | NCT02430636 | Stomach Neoplasms -IRE-01 | IRE | January 2015 | January 2017 | January 2020 | April 30, 2015 | March 29, 2016 |
|
|
16 | NCT02777801 | Recruiting | Prophylactic or Preemptive Entecavir in Patients With Gastric Cancer Who Are Inactive Hepatitis B Carriers |
|
|
Interventional | Phase 2 |
|
Other |
|
|
50 | All | 18 Years to 75 Years (Adult, Senior) | NCT02777801 | GC-HBV | June 2015 | December 2017 | June 2018 | May 19, 2016 | October 13, 2017 |
|
||
17 | NCT02289547 | Recruiting | Phase 3 Study of Xelox Followed by Maintenance Capecitabine in the Advanced Gastric Cancer |
|
|
Interventional | Phase 3 |
|
Other |
|
|
184 | All | 18 Years and older (Adult, Senior) | NCT02289547 | CMCGA1 Trial | May 2015 | January 2018 | January 2019 | November 13, 2014 | June 14, 2017 |
|
||
18 | NCT03046745 | Recruiting | Gastric Cancer Registry for Epidemiology and Molecular Risk Factor |
|
Observational |
|
Other |
|
|
18000 | All | 18 Years and older (Adult, Senior) | NCT03046745 | KNUMC 2016-07-014 | August 2016 | April 2021 | April 2022 | February 8, 2017 | March 27, 2018 |
|
||||
19 | NCT03399110 | Recruiting | Compare Chemotherapy of XELOX for 4 Months to 6 Months After D2 Gastrectomy for Gastric Cancer Staged II or III. |
|
|
Interventional | Phase 3 |
|
Other |
|
|
1146 | All | 18 Years to 75 Years (Adult, Senior) | NCT03399110 | GCGC005 | December 1, 2017 | December 1, 2022 | December 1, 2025 | January 16, 2018 | January 16, 2018 |
|
||
20 | NCT03399253 | Recruiting | Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor |
|
|
Interventional | Phase 2 Phase 3 |
|
Other |
|
|
120 | All | 18 Years to 75 Years (Adult, Senior) | NCT03399253 | GCGC004 | December 10, 2017 | November 1, 2022 | December 1, 2025 | January 16, 2018 | January 16, 2018 |
|
||
21 | NCT02555358 | Recruiting | Three Drugs in Advanced Gastric Cancer Neoadjuvant Chemotherapy for Stage Ⅲ Clinical Study |
|
|
Interventional | Phase 3 |
|
Other / Industry |
|
|
300 | All | 20 Years to 60 Years (Adult) | NCT02555358 | Alien Craft 0004 | November 2014 | December 2017 | December 2017 | September 21, 2015 | October 9, 2017 |
|
||
22 | NCT03121729 | Recruiting | Enhanced Recovery After Surgery Program for Gastric Cancer: a Multi-center Study |
|
|
Interventional | Not Applicable |
|
Other |
|
|
1000 | All | 18 Years to 75 Years (Adult, Senior) | NCT03121729 | BE2015687 | ERASG1 | June 21, 2017 | January 2018 | May 2018 | April 20, 2017 | January 19, 2018 |
|
|
23 | NCT02114359 | Recruiting | Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer |
|
|
Interventional | Phase 3 |
|
Other |
|
|
246 | All | 70 Years and older (Senior) | NCT02114359 | 20140113/16-2014-9/021 | February 2014 | February 2019 | February 2020 | April 15, 2014 | April 20, 2018 |
|
||
24 | NCT03484949 | Recruiting New |
Web-Mediated Risk Assessment for Endoscopic Screening of Gastric Cancer |
|
|
Interventional | Not Applicable |
|
Other |
|
|
1000 | All | 18 Years to 65 Years (Adult) | NCT03484949 | xjtu-20170816 | December 1, 2017 | December 1, 2019 | December 1, 2020 | April 2, 2018 | April 18, 2018 |
|
||
25 | NCT03104283 | Recruiting | Apatinib for the Elderly Advanced Gastric Cancer |
|
|
Interventional | Phase 2 |
|
Other |
|
|
60 | All | 60 Years and older (Adult, Senior) | NCT03104283 | AHQU-2017001 | June 1, 2017 | June 2019 | June 2020 | April 7, 2017 | August 23, 2017 |
|
||
26 | NCT03475615 | Recruiting | A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites |
|
|
Interventional | Phase 3 |
|
Other |
|
|
215 | All | 18 Years and older (Adult, Senior) | NCT03475615 | FDZL-SOXP | March 16, 2018 | December 31, 2020 | December 31, 2020 | March 23, 2018 | March 23, 2018 |
|
||
27 | NCT01917552 | Recruiting | Adjuvant Capecitabine Versus Observation Alone in Curatively Resected Stage IB Gastric Cancer |
|
|
Interventional | Phase 3 |
|
Other / Industry |
|
|
870 | All | 18 Years to 74 Years (Adult, Senior) | NCT01917552 | AMC1301 | November 2013 | August 2021 | September 2021 | August 6, 2013 | July 14, 2017 |
|
||
28 | NCT02931890 | Recruiting | Multicentric Randomised Trial for Resectable Gastric Cancer |
|
|
Interventional | Phase 2 |
|
Other |
|
|
207 | All | 18 Years and older (Adult, Senior) | NCT02931890 | M15CRI NL 55436.031.015 2015-004627-31 |
CRITICS-II | December 21, 2017 | October 2020 | October 2022 | October 13, 2016 | March 29, 2018 |
|
|
29 | NCT02248519 | Recruiting | Laparoscopic Versus Open Gastrectomy for Gastric Cancer |
|
|
Interventional | Not Applicable |
|
Other / Industry |
|
|
210 | All | 18 Years and older (Adult, Senior) | NCT02248519 | NL47444.041.14 | LOGICA | December 2014 | January 2018 | January 2023 | September 25, 2014 | October 25, 2016 |
|
|
30 | NCT03480256 | Not yet recruiting New |
Study to Evaluate SHR6390 Combined With Pyrotinib in Patients With HER2 Positive Gastric Cancer |
|
|
Interventional | Phase 1 |
|
Other / Industry |
|
|
40 | All | 18 Years to 75 Years (Adult, Senior) | NCT03480256 | SHR6390-Id | March 2018 | November 2018 | August 2019 | March 29, 2018 | March 29, 2018 |
|
||
31 | NCT03236051 | Recruiting | Multimodal Analgesia in Laparoscopic Radical Gastrectomy With Gastric Cancer: a Multi-center Study |
|
|
Interventional | Not Applicable |
|
Other / Industry |
|
|
156 | All | 18 Years to 75 Years (Adult, Senior) | NCT03236051 | 2016HR1116 | February 10, 2017 | June 30, 2018 | August 30, 2018 | August 1, 2017 | August 1, 2017 |
|
||
32 | NCT03015298 | Not yet recruiting | Comparing the Diagnostic Role of PET/MRI and of PET/CT Among Patients With Gastric Cancer |
|
|
Observational |
|
Other |
|
|
100 | All | 18 Years to 75 Years (Adult, Senior) | NCT03015298 | Experiment20160901 | January 2017 | December 2017 | June 2018 | January 10, 2017 | January 10, 2017 | ||||
33 | NCT03273920 | Not yet recruiting | Robotic Versus Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy for Locally Advanced Gastric Cancer |
|
|
Interventional | Not Applicable |
|
Other |
|
|
1110 | All | 20 Years to 75 Years (Adult, Senior) | NCT03273920 | CRASS-01 | September 25, 2017 | September 25, 2019 | September 25, 2022 | September 6, 2017 | September 8, 2017 |
|
||
34 | NCT02356276 | Recruiting | Efficacy of HIPEC in the Treatment of Locally Advanced Gastric Cancer After radIcal Gastrectomy With D2 |
|
|
Interventional | Phase 3 |
|
Other |
|
|
584 | All | 18 Years to 70 Years (Adult, Senior) | NCT02356276 | HIPEC-01 | EHTLAGCRGD2 | May 11, 2015 | January 2022 | January 2022 | February 5, 2015 | October 31, 2017 |
|
|
35 | NCT03117023 | Not yet recruiting | The Addition of Dexmedetomidine on Postoperative Sleep for Middle-aged and Elderly Patients With Gastric Cancer |
|
|
Interventional | Phase 3 |
|
Other |
|
|
50 | All | 55 Years and older (Adult, Senior) | NCT03117023 | 2017NLY002 | April 15, 2017 | May 15, 2017 | June 1, 2017 | April 17, 2017 | April 17, 2017 | |||
36 | NCT02867839 | Recruiting | Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric Cancer |
|
|
Interventional | Phase 3 |
|
Other |
|
|
564 | All | 18 Years to 69 Years (Adult, Senior) | NCT02867839 | RESCUE-GC-2016 | RESCUE-GC | April 24, 2017 | February 10, 2022 | February 10, 2024 | August 16, 2016 | November 7, 2017 |
|
|
37 | NCT03007446 | Recruiting | The Study of Conversion Surgery for Apatinib in Combination With SOX for Patients With Unresectable Gastric Cancer |
|
|
Interventional | Phase 2 |
|
Other |
|
|
20 | All | 18 Years to 70 Years (Adult, Senior) | NCT03007446 | Ahead-BG301 | November 2016 | November 2018 | November 2018 | January 2, 2017 | September 27, 2017 |
|
||
38 | NCT02855788 | Recruiting | Metronomic Chemotherapy in Advanced Gastric Cancer |
|
|
Interventional | Phase 2 |
|
Other |
|
|
40 | All | 18 Years to 70 Years (Adult, Senior) | NCT02855788 | KY2016-206 | May 2015 | July 2018 | October 2018 | August 4, 2016 | August 4, 2016 |
|
||
39 | NCT03154983 | Recruiting | The Clinical Research of Mesylate Apatinib Combined With Docetaxel and S-1 as the First-line Treatment of Metastatic Gastric Cancer |
|
|
Interventional | Phase 2 |
|
Other |
|
|
48 | All | 18 Years to 70 Years (Adult, Senior) | NCT03154983 | HCCSC G04 | May 20, 2017 | February 20, 2018 | November 20, 2019 | May 16, 2017 | October 19, 2017 |
|
||
40 | NCT03314649 | Recruiting | Peritoneal Lavage for Early Detecting Gene Mutation of Peritoneal Metastasis of Gastric Cancer |
|
|
Observational |
|
Other |
|
|
200 | All | 18 Years to 80 Years (Adult, Senior) | NCT03314649 | CGCG003 | December 21, 2017 | October 2021 | October 2023 | October 19, 2017 | January 10, 2018 |
|
|||
41 | NCT02736552 | Recruiting | Compare S-1 for 6 Months to 1 Year as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer Staged II , IIIA or IIIB. |
|
|
Interventional | Phase 3 |
|
Other / Industry |
|
|
680 | All | 18 Years to 75 Years (Adult, Senior) | NCT02736552 | CGCG001 | March 2016 | March 2018 | March 2023 | April 13, 2016 | April 19, 2016 |
|
||
42 | NCT03425058 | Recruiting | Molecular Evaluation of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer |
|
Observational |
|
Other |
|
|
80 | All | 18 Years and older (Adult, Senior) | NCT03425058 | 2017YJZ38 | MENCA-GC | November 22, 2017 | December 31, 2018 | December 31, 2018 | February 7, 2018 | February 8, 2018 |
|
|||
43 | NCT02748551 | Recruiting | A Comparison Laparoscopic With Open Gastric Cancer Surgery for Locally Advanced Gastric Cancer |
|
|
Interventional | Phase 3 |
|
Other |
|
|
800 | All | 18 Years to 82 Years (Adult, Senior) | NCT02748551 | MKNC 01/2016 | April 2016 | April 2018 | April 2022 | April 22, 2016 | December 13, 2016 |
|
||
44 | NCT02668380 | Recruiting | An Open Label, Prospective, Multicentre, Non-interventional Study of Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric Cancer |
|
Observational |
|
Other / Industry |
|
|
300 | All | 18 Years and older (Adult, Senior) | NCT02668380 | AHEAD-G202 | AHEAD-G202 | September 2015 | March 2018 | May 2019 | January 29, 2016 | January 29, 2016 |
|
|||
45 | NCT02674373 | Recruiting | Prognostic and Predictive Impact of Circulating Tumor DNA in Gastric Cancer Treatment |
|
Observational |
|
Other |
|
|
200 | All | 18 Years and older (Adult, Senior) | NCT02674373 | NI-GC-DNAc | PLAGAST | September 2015 | September 2017 | September 2019 | February 4, 2016 | February 4, 2016 |
|
|||
46 | NCT01787539 | Recruiting | The Role of Postoperative Cycles in the Perioperative Chemotherapy for Gastric Cancer |
|
|
Interventional | Phase 2 Phase 3 |
|
Other |
|
|
180 | All | 18 Years and older (Adult, Senior) | NCT01787539 | GC-COMB-0254/275/2012-MUL GC-0254/282/2011/275/2012-MUL |
STOPEROPCHEM | February 2013 | February 2017 | February 2022 | February 8, 2013 | February 8, 2013 |
|
|
47 | NCT02969148 | Recruiting | Laparoscopic Bursectomy and D2 Lymphadenectomy vs.Laparoscopic D2 Lymphadenectomy in Advanced Gastric Cancer |
|
|
Interventional | Not Applicable |
|
Other |
|
|
100 | All | 18 Years to 80 Years (Adult, Senior) | NCT02969148 | LBDL1 | LBDL | November 2016 | November 2022 | November 2024 | November 21, 2016 | November 21, 2016 |
|
|
48 | NCT02976142 | Not yet recruiting | The Efficacy of Surgical Treatment After Neoadjuvant Chemotherapy Plus Intraperitoneal Immunotherapy Versus Chemotherapy Alone for Patients With Positive Wash Cytology Gastric Cancer |
|
|
Interventional | Phase 2 |
|
Other |
|
|
150 | All | 18 Years to 80 Years (Adult, Senior) | NCT02976142 | MKNC02/2016 | December 2016 | November 2018 | December 2020 | November 29, 2016 | December 13, 2016 | |||
49 | NCT02529878 | Recruiting | Study of Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in Unresectable Gastric Cancer |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
30 | All | 20 Years to 75 Years (Adult, Senior) | NCT02529878 | ECGC-0001 | August 2015 | August 2016 | August 2019 | August 20, 2015 | July 26, 2016 |
|
||
50 | NCT03476057 | Recruiting | Next-generation Sequencing in Gastric Cancer to Evaluation Prognosis |
|
|
Observational |
|
Other |
|
|
40 | All | Child, Adult, Senior | NCT03476057 | FNF-009 | July 1, 2017 | December 31, 2018 | January 31, 2019 | March 23, 2018 | March 23, 2018 |
|
† Study has passed its completion date and status has not been verified in more than two years.